Search
for
Sort by
Research 271–300 of 1000+
- Medicinal Plants and their Constituents in the Treatment of Acne vulgaris
- Differential impact of environmental factors on systemic and localized autoimmunity
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Myo-Inositol for Cutaneous Manifestations of Polycystic Ovary Syndrome: An International Delphi Consensus Recommendation for Dermatology Practice
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Autologous Stem Cell-derived Therapies for Androgenetic Alopecia: A Systematic Review of Randomized Control Trials on Efficacy, Safety, and Outcomes
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- A Review On Minoxidil a Potent Hair growth Agent
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Injectable “Skin Boosters” in Aging Skin Rejuvenation: A Current Overview
- COMPARISON OF EFFECTIVENESS OF TOPICAL TACROLIMUS AND BETAMETHASONE WITH SOFT PARAFFIN IN THE TREATMENT OF PATCHY ALOPECIA AREATA
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- GPCRs as key regulators in wound healing
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration